-

Spectrum Solutions Receives CE Mark Approval for its SDNA-2000 and SDNA-3000 Saliva Collection Devices used for IVD Molecular Diagnostic Testing

SALT LAKE CITY--(BUSINESS WIRE)--Spectrum Solutions, LLC today announced receiving CE Mark approval for the sale and distribution of its groundbreaking SDNA saliva collection device for IVD molecular diagnostic testing throughout Europe. The Spectrum SDNA-2000 model has been approved for integration in over the counter at-home testing kits with the SDNA-3000 model approved for prescription-only molecular diagnostic IVD testing applications.

“Receiving CE Mark approval for the SDNA-2000 and SDNA-3000 is a major milestone for our company and this offers physicians, healthcare organizations, governments, and individuals needing repeat IVD diagnostic testing an easy and pain-free option,” said Stephen Fanning, CEO of Spectrum Solutions. “At-home bio-sample self-collection means staying home when you don’t feel good and limiting exposure to other harmful illnesses for those most at risk.”

The Spectrum Solutions SDNA Saliva Collection Device was the first saliva-based diagnostic testing solution to receive the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for COVID-19 testing in the United States.

Bio-samples collected with the SDNA saliva collection system consistently demonstrate higher levels of testing accuracy, provide the safest & most robust testing biomaterial, is able to pinpoint an infection’s lifecycle stage, and delivers over 10 days of post-collection stability with no degradation in sample efficacy. The device’s intuitive ease-of-use design was engineered to facilitate unsupervised testing sample self-collection virtually eliminating user collection errors.

ABOUT SPECTRUM SOLUTIONS AND SPECTRUM DNA

Headquartered in Salt Lake City, Utah, Spectrum Solutions and its medical device and services division, Spectrum DNA, focus their concentrated industry expertise on engineering innovative end-to-end solutions for both clinical diagnostic projects and commercial product plans. Spectrum Solutions is a single-source provider of on-site medical device development and manufacturing, custom packaging, kitting, and direct-to-consumer fulfillment. Its bio-sample collection devices, patented technologies, and dedicated services deliver measurable process optimization, unprecedented efficiency, and unmatched global scalability. For more information, please visit spectrumsolution.com/SDNA.

Contacts

Tim Rush
Springboard5
801-208-1100
tim.rush@springboard5.com

Spectrum Solutions, LLC


Release Summary
Spectrum Solutions, LLC received CE Mark approval for its SDNA saliva collection device for IVD molecular diagnostic testing throughout Europe.
Release Versions

Contacts

Tim Rush
Springboard5
801-208-1100
tim.rush@springboard5.com

More News From Spectrum Solutions, LLC

Seattle Study Club Partners with SimplyTest to Advance Cutting-Edge Saliva Testing in Dentistry

SEATTLE--(BUSINESS WIRE)--SimplyTest®, a trusted leader in salivary diagnostics, has partnered with Seattle Study Club (SSC), one of the world’s most respected dental professional networks. As SSC’s exclusive saliva testing partner, SimplyTest will deliver advanced, wellness-focused diagnostics and education to elevate care across the SSC community. "What stands out to me about SimplyTest is their focus on comprehensive, patient-centered wellness,” said Natasha Rodriguez, Director of Education...

SimplyTest Partners with Evexia Diagnostics to Expand Access to PERIO and 4-Point Cortisol Tests for Functional and Integrative Health Practitioners

SALT LAKE CITY--(BUSINESS WIRE)--SimplyTest® is proud to announce a new partnership with Evexia Diagnostics, a premier provider of diagnostic laboratory services for functional and integrative medicine. Through this collaboration, two of SimplyTest’s targeted assessments, the SimplyTest PERIO and 4-Point Cortisol, are now available through Evexia’s comprehensive ordering platform, empowering healthcare practitioners with new tools for personalized, data-driven care. Evexia Diagnostics has serve...

SimplyTest Launches Innovative Saliva-Based Oral HPV Test for Early Detection of Cancer-Linked Strains

SALT LAKE CITY--(BUSINESS WIRE)--SimplyTest® has launched a groundbreaking saliva-based test to detect high-risk strains of oral human papillomavirus (HPV), a major cause of oropharyngeal cancers. Designed for use in dental and functional medicine practices, SimplyTest Oral HPV test provides a simple, accurate alternative to traditional screening methods. “As we continue to expand the SimplyTest platform, our mission remains clear: to make advanced diagnostic insights available at the very firs...
Back to Newsroom